Ganbarlı, N. Et Al. 2018. The Prognostic Significance of Preoperative CA 19-9, Neutrophil / Lymphosit And Platelet / Lymphosit Ratio in Patients with Pancreatic Ductal Adenocarcinoma. journal of pharmacology and clinical research , vol.6, no.4 , 555692.

Ganbarlı, N., DİKMEN, K., BOSTANCI, H., BÜYÜKKASAP, A. Ç., KEREM, M., & TANERİ, F., (2018). The Prognostic Significance of Preoperative CA 19-9, Neutrophil / Lymphosit And Platelet / Lymphosit Ratio in Patients with Pancreatic Ductal Adenocarcinoma. journal of pharmacology and clinical research , vol.6, no.4, 555692.

Ganbarlı, Niyazi Et Al. "The Prognostic Significance of Preoperative CA 19-9, Neutrophil / Lymphosit And Platelet / Lymphosit Ratio in Patients with Pancreatic Ductal Adenocarcinoma," journal of pharmacology and clinical research , vol.6, no.4, 555692, 2018

Ganbarlı, Niyazi Et Al. "The Prognostic Significance of Preoperative CA 19-9, Neutrophil / Lymphosit And Platelet / Lymphosit Ratio in Patients with Pancreatic Ductal Adenocarcinoma." journal of pharmacology and clinical research , vol.6, no.4, pp.555692, 2018

Ganbarlı, N. Et Al. (2018) . "The Prognostic Significance of Preoperative CA 19-9, Neutrophil / Lymphosit And Platelet / Lymphosit Ratio in Patients with Pancreatic Ductal Adenocarcinoma." journal of pharmacology and clinical research , vol.6, no.4, p.555692.

@article{article, author={Niyazi Ganbarlı Et Al. }, title={The Prognostic Significance of Preoperative CA 19-9, Neutrophil / Lymphosit And Platelet / Lymphosit Ratio in Patients with Pancreatic Ductal Adenocarcinoma}, journal={journal of pharmacology and clinical research}, year=2018, pages={555692} }